COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies-Reference-Cited by-同舟云学术

COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies

Published:2020-09-29 Issue:4 Volume:17 Page:1122-1127
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Rele Shyam¹

Affiliation:

1. Principal Consultant, Scientific Strategy, Product Development, Manufacturing, Outsourcing and Emerging Technologies, Gaithersburg, MD, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1822136

Reference11 articles.

1. The World Bank. Feature story. The global economic outlook during the COVID-19 pandemic: a changed world. 2020 Jun 8. https://www.worldbank.org/en/news/feature/2020/06/08/the-global-economic-outlook-during-the-covid-19-pandemic-a-changed-world.

2. Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats

3. IABS WEBINAR, Dr Melanie Saville. https://www.iabs.org/documents/conferences/2020/sars-cov-2-webinar/1376-melanie-saville-2705-vaccine-development-for-covdi19-ms-cepi/file.

4. Developing Covid-19 Vaccines at Pandemic Speed

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers.;2024-07-12

2. Integration of Dendrimer‐Based Delivery Technologies with Computational Pharmaceutics and Their Potential in the Era of Nanomedicine;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

3. Designing a sustainable-resilient-responsive supply chain network considering uncertainty in the COVID-19 era;Expert Systems with Applications;2023-10

4. Designing a vaccine supply chain network considering environmental aspects;Journal of Cleaner Production;2023-09

5. Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine;Nanomedicine;2023-08